ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft-Reference-Cited by-同舟云学术

ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft

Published:2008-12 Issue:6 Volume:49 Page:985-997
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Jasinghe Viraj J.,Xie Zhigang,Zhou Jianbiao,Khng Jiaying,Poon Lai-Fong,Senthilnathan Palaniyandi,Glaser Keith B.,Albert Daniel H.,Davidsen Steven K.,Chen Chien-Shing

Publisher

Elsevier BV

Subject

Hepatology

Reference55 articles.

1. Estimating future hepatitis C morbidity, mortality, and costs in the United States;Wong;Am J Public Health,2000

2. Estimates of the worldwide incidence of 25 major cancers in 1990;Parkin;Int J Cancer,1999

3. Increase in primary liver cancer in the UK, 1979–94;Taylor-Robinson;Lancet,1997

4. Trends in primary liver cancer;Deuffic;Lancet,1998

5. Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years;Nagasue;Ann Surg,1993

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges;Molecules;2022-08-28

2. Cross-talk between HIF and PD-1/PD-L1 pathways in carcinogenesis and therapy;Journal of Clinical Investigation;2022-05-02

3. Anti-Hepatocellular Carcinoma Biomolecules: Molecular Targets Insights;International Journal of Molecular Sciences;2021-10-06

4. Novel molecular targets in hepatocellular carcinoma;World Journal of Clinical Oncology;2020-08-24

5. New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma;Cancers;2019-07-31